Rhythm Pharmaceuticals (RYTM) Short Interest Ratio & Short Volume $56.23 -3.54 (-5.92%) (As of 11/15/2024 ET) Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends Rhythm Pharmaceuticals Short Interest DataRhythm Pharmaceuticals (RYTM) has a short interest of 8.36 million shares. This marks a -1.18% decrease in short interest from the previous month. The short interest ratio (days to cover) is 18.3, indicating that it would take 18.3 days of the average trading volume of 547,778 shares to cover all short positions.Current Short Interest8,360,000 sharesPrevious Short Interest8,460,000 sharesChange Vs. Previous Month-1.18%Dollar Volume Sold Short$399.02 millionShort Interest Ratio18.3 Days to CoverLast Record DateOctober 31, 2024Outstanding Shares61,460,000 sharesPercentage of Shares Shorted13.60%Today's Trading Volume690,306 sharesAverage Trading Volume547,778 sharesToday's Volume Vs. Average126% Short Selling Rhythm Pharmaceuticals? Sign up to receive the latest short interest report for Rhythm Pharmaceuticals and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartRYTM Short Interest Over TimeRYTM Days to Cover Over TimeRYTM Percentage of Float Shorted Over Time Ad Crypto Swap Profits[625,000% Gain] – Are You Ready for the Next Altcoin Boom?All of our key indicators are flashing the same signal: an altcoin season is fast approaching. And if you know anything about crypto, you know that altcoin seasons are where some of the biggest gains happen.Register for the FREE Workshop Now & get $10 in Bitcoin Rhythm Pharmaceuticals Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 10/31/20248,360,000 shares $399.02 million -1.2%N/A18.3 $47.73 10/15/20248,460,000 shares $426.47 million +2.8%N/A21.6 $50.41 9/30/20248,230,000 shares $431.17 million -11.9%N/A19.1 $52.39 9/15/20249,340,000 shares $463.45 million -3.1%N/A20.1 $49.62 8/31/20249,640,000 shares $455.88 million -2.4%N/A20.5 $47.29 8/15/20249,880,000 shares $461.40 million -3.0%N/A20 $46.70 Get the Latest News and Ratings for RYTM and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Rhythm Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 7/31/202410,180,000 shares $490.78 million +1.1%N/A19.7 $48.21 7/15/202410,070,000 shares $522.63 million +9.0%N/A18.3 $51.90 6/30/20249,240,000 shares $379.39 million -16.3%N/A16.9 $41.06 6/15/202411,040,000 shares $472.18 million +1.1%N/A19.8 $42.77 5/31/202410,920,000 shares $389.63 million +5.8%N/A19.7 $35.68 5/15/202410,320,000 shares $408.67 million -2.6%N/A18.7 $39.60 4/30/202410,590,000 shares $421.06 million +3.8%N/A17.5 $39.76 4/15/202410,200,000 shares $408.92 million +4.7%N/A17.1 $40.09 3/31/20249,740,000 shares $422.03 million +5.9%N/A15.4 $43.33 3/15/20249,200,000 shares $368 million +2.2%N/A13.7 $40.00 2/29/20249,000,000 shares $390.78 million +2.7%N/A12.3 $43.42 2/15/20248,760,000 shares $442.12 million -1.1%N/A11.7 $50.47 1/31/20248,860,000 shares $390.81 million +4.9%N/A11.6 $44.11 1/15/20248,450,000 shares $343.75 million +3.8%N/A11.7 $40.68 12/31/20238,140,000 shares $374.20 million -5.8%N/A11.5 $45.97 12/15/20238,640,000 shares $407.81 million -6.6%N/A13.2 $47.20 11/30/20239,250,000 shares $309.23 million -1.7%N/A15.2 $33.43 11/15/20239,410,000 shares $301.78 million -19.2%N/A16.5 $32.07 10/31/202311,650,000 shares $269.23 million -1.2%23.2%19.9 $23.11 10/15/202311,790,000 shares $294.51 million +16.9%23.6%17.3 $24.98 9/30/202310,090,000 shares $231.31 million -15.8%20.2%14.6 $22.93 9/15/202311,980,000 shares $299.02 million +12.5%24.0%16.8 $24.96 8/31/202310,650,000 shares $277.01 million -2.8%21.3%13.3 $26.01 8/15/202310,960,000 shares $287.04 million -11.7%22.0%13.7 $26.19 7/31/202312,410,000 shares $221.39 million +8.1%N/A16.1 $17.84 7/15/202311,480,000 shares $182.88 million +4.4%N/A16.2 $15.93 6/30/202311,000,000 shares $181.39 million +10.8%N/A15.4 $16.49 6/15/20239,930,000 shares $181.52 million +2.5%N/A13.6 $18.28 5/31/20239,690,000 shares $161.44 million +8.0%N/A15.2 $16.66 5/15/20238,970,000 shares $151.50 million +6.0%N/A12.7 $16.89 4/30/20238,460,000 shares $170.64 million +3.6%N/A12.7 $20.17 4/15/20238,170,000 shares $158.50 million +1.6%N/A13 $19.40 3/31/20238,040,000 shares $143.43 million +8.9%N/A12.5 $17.84 3/15/20237,380,000 shares $134.54 million -9.0%15.0%12.1 $18.23[Urgent] Starlink Set For The Largest IPO In History? (Ad)He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again with Tesla… which is up more than 19,500% since 2010. For perspective, that turns $100 invested into almost $20,000! And now, Elon could be set to do it for the third and final time… with what might be his biggest breakthrough yet. And for the first time ever, you have the rare chance to profit BEFORE the upcoming IPO.Click here now for the urgent details on this hidden play. 2/28/20238,110,000 shares $197.15 million -0.4%16.6%13.2 $24.31 2/15/20238,140,000 shares $214.57 million +5.2%16.8%15 $26.36 1/31/20237,740,000 shares $211.69 million -2.4%16.0%12.9 $27.35 1/15/20237,930,000 shares $247.81 million +1.2%16.4%12.7 $31.25 12/30/20227,840,000 shares $228.30 million -3.1%16.2%12.5 $29.12 12/15/20228,090,000 shares $228.95 million +2.8%16.7%11.7 $28.30 11/30/20227,870,000 shares $210.68 million -6.8%16.3%7.9 $26.77 11/15/20228,440,000 shares $222.14 million +0.5%17.4%8 $26.32 10/31/20228,400,000 shares $211.43 million +10.2%17.4%7.4 $25.17 10/15/20227,620,000 shares $169.24 million -0.1%15.8%5.6 $22.21 9/30/20227,630,000 shares $186.94 million +26.5%16.1%3.1 $24.50 9/15/20226,030,000 shares $140.56 million +3.8%12.7%2.4 $23.31 8/31/20225,810,000 shares $131.31 million +3.8%13.4%2.3 $22.60 8/15/20225,600,000 shares $148.12 million -22.7%13.0%2.3 $26.45 7/31/20227,240,000 shares $91.22 million +21.9%16.9%3.1 $12.60 7/15/20225,940,000 shares $59.46 million +87.4%13.8%2.8 $10.01 6/30/20223,170,000 shares $13.16 million -13.6%7.4%3.2 $4.15 6/15/20223,670,000 shares $12.66 million +2.2%8.5%4.2 $3.45 5/31/20223,590,000 shares $12.35 million +15.8%8.4%6.8 $3.44 5/15/20223,100,000 shares $10.04 million -9.4%7.2%5.8 $3.24 4/30/20223,420,000 shares $21.41 million -7.3%8.0%6.2 $6.26 4/15/20223,690,000 shares $32.66 million -1.6%8.6%6.6 $8.85 3/31/20223,750,000 shares $43.20 million -22.2%8.7%6.5 $11.52 3/15/20224,820,000 shares $47.09 million +5.7%11.2%8.7 $9.77 2/28/20224,560,000 shares $34.75 million +4.4%10.6%9 $7.62 2/15/20224,370,000 shares $29.67 million +5.6%10.2%9 $6.79 1/31/20224,140,000 shares $30.68 million +5.1%9.7%10.9 $7.41 1/15/20223,940,000 shares $35.58 million +1.0%9.2%11.4 $9.03 12/31/20213,900,000 shares $38.92 million +2.1%9.1%11.4 $9.98 12/15/20213,820,000 shares $38.89 million +3.0%8.9%11 $10.18 11/30/20213,710,000 shares $33.20 million -1.3%8.7%12.4 $8.95 11/15/20213,760,000 shares $49.74 million -3.8%8.8%13.4 $13.23 10/29/20213,910,000 shares $45.00 million +0.3%9.1%14.3 $11.51 10/15/20213,900,000 shares $44.11 million +4.8%9.1%13 $11.31 9/30/20213,720,000 shares $48.58 million -0.3%8.7%13 $13.06 9/15/20213,730,000 shares $46.92 million -9.7%8.7%11.6 $12.58 8/31/20214,130,000 shares $53.73 million -6.1%9.6%11.7 $13.01 8/13/20214,400,000 shares $60.98 million -7.6%10.3%11.8 $13.86 7/30/20214,760,000 shares $82.30 million +9.2%11.1%12.6 $17.29 7/15/20214,360,000 shares $82.45 million +15.3%10.3%13.1 $18.91 6/30/20213,780,000 shares $74.01 million -1.6%9.0%10.7 $19.58 6/15/20213,840,000 shares $82.56 million +11.6%9.1%11.2 $21.50 5/28/20213,440,000 shares $67.46 million -2.8%8.2%9.4 $19.61 5/14/20213,540,000 shares $74.98 million -3.0%N/A9.4 $21.18 4/30/20213,650,000 shares $78.48 million -0.5%N/A8.7 $21.50 4/15/20213,670,000 shares $76.15 million -11.8%N/A7.4 $20.75 3/31/20214,160,000 shares $84.57 million +54.1%N/A8.6 $20.33 3/15/20212,700,000 shares $70.44 million -1.5%N/A5.3 $26.09 2/26/20212,740,000 shares $70.25 million -6.8%N/A5.8 $25.64 2/12/20212,940,000 shares $90.14 million -1.0%N/A5.9 $30.66[Urgent] Starlink Set For The Largest IPO In History? (Ad)He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again with Tesla… which is up more than 19,500% since 2010. For perspective, that turns $100 invested into almost $20,000! And now, Elon could be set to do it for the third and final time… with what might be his biggest breakthrough yet. And for the first time ever, you have the rare chance to profit BEFORE the upcoming IPO.Click here now for the urgent details on this hidden play. 1/29/20212,970,000 shares $94.09 million -15.4%N/A6.4 $31.68 1/15/20213,510,000 shares $119.09 million +27.2%N/A8.4 $33.93 12/31/20202,760,000 shares $82.74 million +55.9%N/A7.7 $29.98 12/15/20201,770,000 shares $53.44 million -14.5%N/A5.2 $30.19 11/30/20202,070,000 shares $60.59 million +9.0%N/A6.4 $29.27 11/15/20201,900,000 shares $41.91 million +6.2%N/A6 $22.06 10/30/20201,790,000 shares $38.47 million -11.8%N/A6 $21.49 10/15/20202,030,000 shares $50.28 million +1.0%N/A7.1 $24.77 9/30/20202,010,000 shares $43.56 million -2.4%N/A7 $21.67 9/15/20202,060,000 shares $62.23 million +8.4%N/A7.1 $30.21 8/31/20201,900,000 shares $56.07 million -1.0%N/A7 $29.51 8/14/20201,920,000 shares $34.81 million -2.0%N/A10.2 $18.13 7/31/20201,960,000 shares $37.67 million +2.1%5.8%10.1 $19.22 7/15/20201,920,000 shares $41.43 million +9.1%5.7%9.8 $21.58 6/30/20201,760,000 shares $39.25 million +4.8%5.2%8.3 $22.30 6/15/20201,680,000 shares $34.47 million +7.0%5.0%7.6 $20.52 5/29/20201,570,000 shares $31.15 million -13.3%4.7%6.5 $19.84 5/15/20201,810,000 shares $33.50 million +25.7%5.4%7.2 $18.51 4/30/20201,440,000 shares $28.45 million -16.3%4.3%5.8 $19.76 4/15/20201,720,000 shares $28.93 million -12.2%5.1%6.7 $16.82 3/31/20201,960,000 shares $38.34 million +22.8%5.9%7.4 $19.56 3/13/20201,596,300 shares $26.88 million -30.9%8.4%6.7 $16.84 2/28/20202,310,000 shares $32.29 million +34.3%12.1%9.6 $13.98 2/14/20201,720,000 shares $28.10 million -13.1%5.2%6.7 $16.34 1/31/20201,980,000 shares $37.84 million -7.0%6.0%7.5 $19.11 1/15/20202,130,000 shares $38.06 million -28.0%6.7%7.7 $17.87 12/31/20192,960,000 shares $53.19 million +15.6%11.8%10.2 $17.97 RYTM Short Interest - Frequently Asked Questions What is Rhythm Pharmaceuticals' current short interest? Short interest is the volume of Rhythm Pharmaceuticals shares that have been sold short but have not yet been closed out or covered. As of October 31st, traders have sold 8,360,000 shares of RYTM short. Learn More on Rhythm Pharmaceuticals' current short interest. What is a good short interest ratio for Rhythm Pharmaceuticals? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. RYTM shares currently have a short interest ratio of 18.0. Learn More on Rhythm Pharmaceuticals's short interest ratio. Which institutional investors are shorting Rhythm Pharmaceuticals? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Rhythm Pharmaceuticals: Jane Street Group LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. Is Rhythm Pharmaceuticals' short interest increasing or decreasing? Rhythm Pharmaceuticals saw a decline in short interest during the month of October. As of October 31st, there was short interest totaling 8,360,000 shares, a decline of 1.2% from the previous total of 8,460,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Rhythm Pharmaceuticals' short interest compare to its competitors? Here is how the short interest of companies in the sector of "medical" compare to Rhythm Pharmaceuticals: Morphic Holding, Inc. (3.79%), Arvinas, Inc. (12.81%), Pliant Therapeutics, Inc. (11.86%), Annexon, Inc. (7.35%), Theravance Biopharma, Inc. (10.93%), Viatris Inc. (2.09%), Summit Therapeutics Inc. (2.31%), Genmab A/S (0.37%), Vaxcyte, Inc. (7.16%), Dr. Reddy's Laboratories Limited (1.28%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Charter Communications, Inc. ($4.08 billion), AppLovin Co. ($3.18 billion), Paychex, Inc. ($2.64 billion), Nu Holdings Ltd. ($2.54 billion), International Paper ($2.46 billion), Cencora, Inc. ($2.27 billion), Moderna, Inc. ($1.87 billion), SoFi Technologies, Inc. ($1.81 billion), Lululemon Athletica Inc. ($1.75 billion), and Onsemi ($1.71 billion). View all of the most shorted stocks. What does it mean to sell short Rhythm Pharmaceuticals stock? Short selling RYTM is an investing strategy that aims to generate trading profit from Rhythm Pharmaceuticals as its price is falling. RYTM shares are trading down $3.54 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Rhythm Pharmaceuticals? A short squeeze for Rhythm Pharmaceuticals occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of RYTM, which in turn drives the price of the stock up even further. How often is Rhythm Pharmaceuticals' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including RYTM, twice per month. The most recent reporting period available is October, 31 2024. More Short Interest Resources from MarketBeat Related Companies MORF Short Interest ARVN Short Interest PLRX Short Interest ANNX Short Interest TBPH Short Interest VTRS Short Interest SMMT Short Interest GMAB Short Interest PCVX Short Interest RDY Short Interest Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:RYTM) was last updated on 11/17/2024 by MarketBeat.com Staff From Our PartnersBill Gates’s Next Big AI Bet: StargateIn February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...Brownstone Research | SponsoredThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredThere is a little known company that is changing warfareWith geo - political instability around the world investors are flocking to defense contract stocks. There...Reticulate | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | SponsoredThe pin that pops the AI bubbleMy new documentary explores the background to this pattern and how and why I believe it will almost certainly ...Porter & Company | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredTrump Wins… But Elon Says Get Ready to BraceTrump's back in the White House, ready to hit the gas on America's comeback. He's taking on the economy wi...Genesis Gold Group | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Rhythm Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Rhythm Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free RYTM Stock Alerts